FDMT · 4D Molecular Therapeutics, Inc. · Documents
$12.93
+0.97 (+8.11%)
At close · Oct 28
Return incl. dividend (before tax)
Market Cap
$863.27M
Shares
72.18M
Volume · Oct 28
1.19M
Avg daily vol (3M)
996.07K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-01-11 | 2022-01-10 | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-11-10 | — | |
| 8-K | — | 2021-10-26 | 2021-10-25 | |
| S-1 | — | 2021-10-26 | — | |
| 8-K | — | 2021-10-13 | 2021-10-10 | |
| 8-K | — | 2021-09-24 | 2021-09-22 | |
| 8-K | — | 2021-08-12 | — | |
| 10-Q | — | 2021-08-12 | 2021-06-30 | |
| 8-K | — | 2021-06-25 | 2021-06-18 | |
| 8-K | — | 2021-05-20 | 2021-05-17 | |
| 10-Q | — | 2021-05-13 | 2021-03-31 | |
| 8-K | — | 2021-05-13 | — | |
| DEFA14A | — | 2021-04-06 | — | |
| DEF 14A | — | 2021-04-06 | 2021-05-17 | |
| 8-K | — | 2021-03-25 | — | |
| 10-K | — | 2021-03-25 | 2020-12-31 | |
| 8-K | — | 2020-12-15 | — | |
| S-1/A | — | 2020-12-10 | — | |
| S-1/A | — | 2020-12-07 | — | |
| S-1 | — | 2020-11-17 | — |
Showing 101–121 of 121 filings
Key facts
CIK
1650648
CUSIP
35104E100
13F (30d)
20 filings
20 filers
Visit website
Investor relations